ArticleBMC medicine2023

A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy.

Amirhossein Bahreyni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.